Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Novel high-capacity matrix excipients for controlled drug release

Outputs and Outcomes

Code

F2018/IOF-Advanced/203

Duration

15 October 2018 → 31 December 2024

Funding

Regional and community funding: Industrial Research Fund

Promotor

An Van Den Bulcke

Research disciplines

Medical and health sciences
- Pharmaceutical technology

Keywords

drug delivery sytems controlled release Excipients drug formulation

Project description

The aim of this project is to bring the developed UGent proprietary polymer technology of poly(2-oxazoline)s (PAOx) for drug delivery to a next level towards valorization and commercialization with the overarching goal of licensing the polymer technology to pharmaceutical companies bringing it into the regulatory track.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by